ChristopherLucastiDO

PubMed

• 15 citations
  A Real-world Patient Registry for Oritavancin Demonstrates Efficacy and Safety Consistent With the Phase 3 SOLO Program.
  Mark Redell, Greg Moeck, Christopher Lucasti, Stephanie Durso, Cynthia Kennedy, Karen Fusaro, Jeff Loutit, Michael N. Dudley> ;Open Forum Infectious Diseases. 2018 Mar 19
• Antibiotic Management and Operative Debridement in Open Fractures of the Hand and Upper Extremity: A Systematic Review.
  Warrender, W. J.,Lucasti, C. J.,Chapman, T. R.,Ilyas, A. M.> ;Hand Clin. 2017 Nov 25
• 73 citations
  Efficacy and safety of ridinilazole compared with vancomycin for the treatment of Clostridium difficile infection: a phase 2, randomised, double-blind, active-controll...
  Richard Vickers, Glenn S. Tillotson, Richard Nathan, Sabine Hazan, John Pullman, Christopher Lucasti, Kenneth Deck, Bruce R. Yacyshyn, Benedict Maliakkal, Yves Pesant,...> ;The Lancet. Infectious Diseases. 2017 Jul 1
• 126 citations
  Phase 2, Dose-Ranging Study of Relebactam with Imipenem-Cilastatin in Subjects with Complicated Intra-abdominal Infection
  Christopher Lucasti, Liviu Vasile, Dorel Sandesc, Donatas Venskutonis, Patrick McLeroth, Mallika Lala, Matthew L. Rizk, Michelle L Brown, Maria C Losada, Alison Pedley...> ;Antimicrobial Agents and Chemotherapy. 2016 Sep 23
• 78 citations
  Multicenter, Double-Blind, Randomized, Phase II Trial To Assess the Safety and Efficacy of Ceftolozane-Tazobactam plus Metronidazole Compared with Meropenem in Adult P...
  Christopher Lucasti, Ellie Hershberger, Benjamin Miller, Sara Yankelev, Judith N. Steenbergen, Ian Friedland, Joseph S. Solomkin> ;Antimicrobial Agents and Chemotherapy. 2014 Sep 1
• 180 citations
  Comparative study of the efficacy and safety of ceftazidime/avibactam plus metronidazole versus meropenem in the treatment of complicated intra-abdominal infections in...
  Christopher Lucasti, Irinel Popescu, Mayakonda K. Ramesh, Joy Lipka, Carole Sable> ;The Journal of Antimicrobial Chemotherapy. 2013 May 1
• 77 citations
  Efficacy and tolerability of IV doripenem versus meropenem in adults with complicated intra-abdominal infection: a phase III, prospective, multicenter, randomized, dou...
  Christopher Lucasti, Abel Jasovich, Obiamiwe Umeh, Joel Jiang, Koné Kaniga, Ian Friedland> ;Clinical Therapeutics. 2008 May 1
• 16 citations
  Enfuvirtide does not require dose adjustment in patients with chronic kidney failure: results of a pharmacokinetic study of enfuvirtide in HIV-1-infected patients with...
  Pablo Tebas, Nicholas C. Bellos, Christopher Lucasti, Gary Richmond, Eliot Godofsky, Indravadan H. Patel, Yu-Yuan Chiu, Claire Evans, Lucy Rowell, Miklos Salgo> ;Journal of Acquired Immune Deficiency Syndromes. 2008 Mar 1
• 70 citations
  Once-Daily, High-Dose Levofloxacin versus Ticarcillin-Clavulanate Alone or Followed by Amoxicillin-Clavulanate for Complicated Skin and Skin-Structure Infections: A Ra...
  Donald R. Graham, David A. Talan, Ronald Lee Nichols, Christopher Lucasti, M. L. Corrado, Nancy Morgan, Cynthia L. Fowler> ;Clinical Infectious Diseases. 2002 Aug 15
• 108 citations
  Ertapenem Once Daily Versus Piperacillin-Tazobactam 4 Times per Day for Treatment of Complicated Skin and Skin-Structure Infections in Adults: Results of a Prospective...
  Donald R. Graham, Christopher Lucasti, Osvaldo Malafaia, Ronald Lee Nichols, Paul Holtom, Nora Quintero Perez, Andrea McAdams, Gail L. Woods, T Paulette Ceesay, Richar...> ;Clinical Infectious Diseases. 2002 Jun 1
• Join now to see all